Inspire Investing, LLC 89bio, Inc. Transaction History
Inspire Investing, LLC
- $858 Million
- Q4 2024
A detailed history of Inspire Investing, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Inspire Investing, LLC holds 51,717 shares of ETNB stock, worth $335,643. This represents 0.05% of its overall portfolio holdings.
Number of Shares
51,717
Previous 56,112
7.83%
Holding current value
$335,643
Previous $415,000
4.58%
% of portfolio
0.05%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
162Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$98.4 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$92 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$51.9 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$47.9 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$45.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $302M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...